DE3687266D1 - Bakterielle enzyme und verfahren fuer deren produktion. - Google Patents

Bakterielle enzyme und verfahren fuer deren produktion.

Info

Publication number
DE3687266D1
DE3687266D1 DE8686106348T DE3687266T DE3687266D1 DE 3687266 D1 DE3687266 D1 DE 3687266D1 DE 8686106348 T DE8686106348 T DE 8686106348T DE 3687266 T DE3687266 T DE 3687266T DE 3687266 D1 DE3687266 D1 DE 3687266D1
Authority
DE
Germany
Prior art keywords
enzymes
production
methods
serratia spp
nuclease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8686106348T
Other languages
English (en)
Other versions
DE3687266T2 (de
Inventor
Soren Molin
Michael Givskov
Erik Riise
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharma AS
Original Assignee
Benzon Pharma AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK210085A external-priority patent/DK210085D0/da
Priority claimed from DK606085A external-priority patent/DK606085D0/da
Application filed by Benzon Pharma AS filed Critical Benzon Pharma AS
Publication of DE3687266D1 publication Critical patent/DE3687266D1/de
Application granted granted Critical
Publication of DE3687266T2 publication Critical patent/DE3687266T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/08—Reducing the nucleic acid content
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C12N15/69—Increasing the copy number of the vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases RNAses, DNAses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • Compounds Of Unknown Constitution (AREA)
DE8686106348T 1985-05-10 1986-05-09 Bakterielle enzyme und verfahren fuer deren produktion. Expired - Lifetime DE3687266T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK210085A DK210085D0 (da) 1985-05-10 1985-05-10 Fremgangsmaade til fremstilling af bakterielle enzymer
DK606085A DK606085D0 (da) 1985-12-23 1985-12-23 Fremgangsmaade til fremstilling af et bakterielt enzym

Publications (2)

Publication Number Publication Date
DE3687266D1 true DE3687266D1 (de) 1993-01-21
DE3687266T2 DE3687266T2 (de) 1993-04-15

Family

ID=26066359

Family Applications (2)

Application Number Title Priority Date Filing Date
DE198686106348T Pending DE229866T1 (de) 1985-05-10 1986-05-09 Bakteriologische enzyme und methode fuer deren produktion.
DE8686106348T Expired - Lifetime DE3687266T2 (de) 1985-05-10 1986-05-09 Bakterielle enzyme und verfahren fuer deren produktion.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE198686106348T Pending DE229866T1 (de) 1985-05-10 1986-05-09 Bakteriologische enzyme und methode fuer deren produktion.

Country Status (13)

Country Link
EP (1) EP0229866B1 (de)
KR (1) KR930002887B1 (de)
CN (1) CN1008377B (de)
AT (1) ATE83264T1 (de)
AU (2) AU594062B2 (de)
CA (1) CA1327328C (de)
DE (2) DE229866T1 (de)
DK (1) DK173445B1 (de)
ES (2) ES8800346A1 (de)
FI (1) FI870052A (de)
IE (1) IE59296B1 (de)
IL (1) IL78703A (de)
WO (1) WO1986006743A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3939771A1 (de) * 1989-12-01 1991-06-06 Behringwerke Ag Verfahren zur biologischen inaktivierung von nukleinsaeuren
IL103846A0 (en) * 1991-11-25 1993-04-04 Tanabe Seiyaku Co Gene coding for esterase and novel microorganism containing said gene
US5834233A (en) * 1992-04-06 1998-11-10 Gx Biosystems A/S Method of limiting the survival of genetically engineered microorganisms in their enivronment
CH682541A5 (de) * 1992-06-23 1993-10-15 Urs Viktor Dr Wirth Biochemische Inaktivierung von RNA-Viren.
CA2137728C (en) * 1993-12-14 1998-07-14 William E. Keating Enzymatic removal of non-target nucleic acid from biological samples
US5968777A (en) * 1996-04-18 1999-10-19 Smithkline Beecham Corporation DNA encoding seryl t-RNA synthetase
PT1539798E (pt) 2002-09-06 2011-02-23 Genentech Inc Processo para extracção de proteínas
WO2008108006A1 (ja) 2007-03-07 2008-09-12 On-Chip Cellomics Consortium 細胞分離方法ならびに細胞検査方法とその試薬キット
EP2108956A1 (de) 2008-04-07 2009-10-14 Erasmus University Medical Center Rotterdam Verbesserte Verfahren und Kits zum Erkennen von tumorspezifischen Fusionsproteinen
PL3192874T3 (pl) 2008-06-18 2020-06-29 Oxford Biomedica (Uk) Limited Oczyszczanie wirusa
EP2462224B1 (de) 2009-08-03 2017-05-10 c-LEcta GmbH Verfahren zur herstellung von nukleasen eines gram-negativen bakteriums unter nutzung eines gram-positiven expressionswirtes
CA2887341C (en) 2012-10-12 2021-03-16 Sage Science, Inc. Side-eluting molecular fractionator
CN103205448B (zh) * 2013-02-18 2016-03-23 徐东 一种裂解时自动降解核酸的大肠杆菌制备的方法
CN104099310B (zh) * 2013-04-12 2021-06-18 杭州俊丰生物工程有限公司 一种重组核酸酶及其制备方法
CN107109487B (zh) 2014-10-15 2022-03-04 赛琪科学股份有限公司 自动处理核酸和电泳样品制备的装置、方法和系统
EP3719141B1 (de) 2015-04-20 2023-01-25 QIAGEN GmbH Verfahren, lyselösung und ausrüstung zur selektiven abreicherung von tierischen nukleinsäuren in einer probe
AU2016357319B2 (en) 2015-11-20 2022-03-10 Sage Science, Inc. Preparative electrophoretic method for targeted purification of genomic DNA fragments
WO2017139669A1 (en) * 2016-02-11 2017-08-17 Sage Science, Inc. Workflows for enzymatic nucleic acid modification
CN110506203A (zh) 2017-04-07 2019-11-26 塞奇科学股份有限公司 用于通过使用集成电泳dna纯化来检测遗传结构变异的系统和方法
JP2021523724A (ja) 2018-05-15 2021-09-09 フラッグシップ パイオニアリング イノベーションズ ブイ， インコーポレイテッド フソソーム組成物およびその使用
AU2019380517A1 (en) 2018-11-14 2021-06-03 Flagship Pioneering Innovations V, Inc. Fusosome compositions for hematopoietic stem cell delivery
AU2019378883A1 (en) 2018-11-14 2021-06-03 Flagship Pioneering Innovations V, Inc. Fusosome compositions for T cell delivery
KR20210133948A (ko) 2018-11-14 2021-11-08 플래그쉽 파이어니어링 이노베이션스 브이, 인크. Cns 전달을 위한 푸소좀 조성물
CN113056478A (zh) 2018-12-21 2021-06-29 一般财团法人阪大微生物病研究会 肉毒毒素的制造方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5315491A (en) * 1976-07-23 1978-02-13 Rikagaku Kenkyusho Preparation of novel nucleicacidase
US4174400A (en) * 1978-09-13 1979-11-13 Merck & Co., Inc. Anthelmintic benzimidazoles
EP0095361B1 (de) * 1982-05-25 1989-07-26 Eli Lilly And Company Klonbildungsvektoren für die Expression von exogenem Protein
JPS59183688A (ja) * 1983-03-31 1984-10-18 Tanabe Seiyaku Co Ltd Ｌ−アスパラギン酸の製法
EP0131418A1 (de) * 1983-07-01 1985-01-16 Celltech Limited Proteine, pharmazeutische Zusammensetzungen, Gene, Vektoren, Wirtorganismen und Verfahren zu deren Herstellung
DE3334847A1 (de) * 1983-09-27 1985-04-04 Hoechst Ag, 6230 Frankfurt Immobilisierte 5'-phosphodiesterase, verfahren zu ihrer herstellung und ihre verwendung

Also Published As

Publication number Publication date
DE229866T1 (de) 1988-01-14
DK9787A (da) 1987-01-09
ATE83264T1 (de) 1992-12-15
EP0229866A1 (de) 1987-07-29
DK173445B1 (da) 2000-11-06
ES557687A0 (es) 1988-03-01
ES8801946A1 (es) 1988-03-01
FI870052A0 (fi) 1987-01-07
AU5910086A (en) 1986-12-04
CN1008377B (zh) 1990-06-13
DE3687266T2 (de) 1993-04-15
ES554856A0 (es) 1987-11-01
AU3679389A (en) 1989-11-23
KR880700069A (ko) 1988-02-15
EP0229866B1 (de) 1992-12-09
CN86104387A (zh) 1987-04-22
WO1986006743A1 (en) 1986-11-20
FI870052A (fi) 1987-01-07
CA1327328C (en) 1994-03-01
KR930002887B1 (ko) 1993-04-12
IL78703A (en) 1993-02-21
IE861236L (en) 1986-11-10
ES8800346A1 (es) 1987-11-01
IL78703A0 (en) 1986-08-31
DK9787D0 (da) 1987-01-09
AU594062B2 (en) 1990-03-01
IE59296B1 (en) 1994-02-09

Similar Documents

Publication Publication Date Title
DE3687266D1 (de) Bakterielle enzyme und verfahren fuer deren produktion.
DE69435030D1 (de) Methode zur Detektion eines DNA Zielmoleküls
PT80930B (pt) Processo de tecnologia genetica para a preparacao de hirudinas
BR8805646A (pt) Processo para amplificacao de genes estaveis em adn cromossomico de microorganismos procarioticos
ATE292141T1 (de) Oligoribonukleotide und ribonucleasen zur spaltung von rns
ATE78868T1 (de) Alkalische protease, verfahren zur herstellung von hybridvektoren und genetisch transformierte mikroorganismen.
FI93858B (fi) Menetelmä amidin valmistamiseksi mikrobiologisesti
IL68366A (en) Process for expressing a gene encoding a protein comprising the enzymatic portion of human urokinase in a microorganism or cell culture
AU7514896A (en) Nucleic acid fragments encoding stereospecific nitrile hydratase and amidase enzymes and recombinant microorganisms expressing those enzymes useful for the production of chiral amides and acides
PT80542B (pt) Processo de tecnologia genetica para a preparacao de interleucina-2 humana
PT81265B (pt) Processo aperfeicoado para a producao de antibioticos derivados do peptideo ciclico a-21978c
FR2708936B1 (fr) Enzymes à activité nitrile-hydratase, outils génétiques et micro-organismes hôtes permettant leur obtention et procédé d'hydrolyse mettant en Óoeuvre lesdites enzymes.
ATE283362T1 (de) Verfahren zur erhöhung der produktion von clavam- antibiotika
IT8621735A1 (it) Microorganismi manipolati con mezzi di ingegneria genetica per la produzione di l-amminoacidi
ES2111745T3 (es) Un metodo de limitar la supervivencia de microorganismos, transformados por ingenieria genetica, en su medio ambiente.
RU95116325A (ru) Штамм бактерий alcaligenes species - продуцент нитрилазы
AU2408988A (en) Method of gene amplification for enhancing protein production in cultured animal cells

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: NYCOMED DANMARK A/S, ROSKILDE, DK